Gilotrif (Afatinib)

Gilotrif (afatinib) is a kinase inhibitor used for:

• First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations. Safety and efficacy of this medicine have not been established in those whose tumors have resistant EGFR mutations.
• Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy.

Recommended Dosage:
The recommended dosage of Afatinib is 40 mg once a day. It needs to be taken by mouth at the same time every day. Take it at least 1 hour before food or 2 hours after; do not eat while the pill is in your stomach. Avoid swallowing Afatinib with a meal.
If you forget a dose and the next one is more than 12 hours away, take the missed pill right away. If the gap is shorter, skip the missed pill and return to your routine. Keep using Afatinib until your doctor says the disease has progressed or side effects become unbearable. Always stick to your doctor's orders and never raise or lower the dose without asking first.

• Treatment with Afatinib 40 mg/30 mg/20 mg tablets may cause serious diarrhea, which can cause dehydration or kidney complications if not treated. Consume plenty of fluids and let your doctor know if diarrhea becomes frequent, even after using anti-diarrheal medicines. Early treatment is very important.
• Skin reactions like severe rashes, blisters, or peeling may occur. These could be signs and symptoms of serious skin conditions. Stop this treatment and contact your healthcare provider (HCP) right away in case you notice blisters, redness, or skin peeling anywhere on the body.
• This therapeutic drug may cause lung inflammation known as interstitial lung disease (ILD). Signs and symptoms include fever, cough, or trouble breathing. Stop treatment and let your doctor know immediately in case you notice new or worsening breathing complications. This condition can be life-threatening and needs quick care.
• Liver complications, including liver damage, can occur with this treatment. Signs may include dark urine, yellowing of skin or eyes, or pain in the upper right stomach area. Regular liver tests are required. Let your doctor know in case you notice any unusual signs and symptoms.
• Though rare, this medicine may be responsible for increasing the risk of a hole forming in the stomach or intestines. Symptoms may include fever, severe stomach pain, or vomiting. Seek immediate medical assistance if you have sharp abdominal pain or notice blood in your stools.
• Inflammation of the cornea (keratitis) can occur with Afatinib 40 mg/30 mg/20 mg tablets. Symptoms include blurred vision, eye redness, pain, or sensitivity to light. Contact your doctor or eye specialist in case you experience any eye complications while on treatment. Avoid ignoring these signs.
• This medicine can cause harm to an unborn baby. Women should not become pregnant while on this medication. Consider an effective birth control method during treatment and for at least 14 days after the final dose. In case pregnancy occurs, let your doctor know immediately for appropriate guidance.
• It is unknown if Athis passes into breast milk. Because of possible harm to a nursing infant, breastfeeding is not required while using this medicinal product and for at least 14 days after stopping treatment. Discuss with your healthcare provider (HCP) before breastfeeding.

What documents are required to import GILOTRIF to India?

GILOTRIF (afatinib) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is GILOTRIF available in India?

GILOTRIF (afatinib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Gilotrif in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Gilotrif 40 mg/30 mg/20 mg price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

GILOTRIF can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of GILOTRIF (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Gilotrif 40 mg/30 mg/20 mg tablets price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source GILOTRIF (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Gilotrif®?

Afatinib is the Generic Name for the trade name drug Gilotrif®.

What is the Manufacturer's Name of Gilotrif®?

Gilotrif® is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

Is Gilotrif approved by the FDA?

Yes. Gilotrif is approved by the US FDA. Date of first approval: July 12, 2013.

What is the dosage and form of Gilotrif® supplied?

Gilotrif is supplied in Tablets: 40 mg, 30 mg, and 20 mg for oral administration.

What are the most common side effects of Gilotrif® 40 mg/30 mg/20 mg Tablets?

The most common side effects of Gilotrif® are stomatitis, diarrhea, rash/acneiform dermatitis, paronychia, dry skin, nausea, decreased appetite, pruritus, and vomiting.

How much does Gilotrif® 40 mg/30 mg/20 mg Tablets cost in India?

Costs of Gilotrif tablets may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Gilotrif 40 mg/30 mg/20 mg cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Gilotrif® 40 mg/30 mg/20 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Gilotrif® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Gilotrif® Tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Gilotrif® 40 mg/30 mg/20 mg Tablets online in India?

Yes, one can buy Gilotrif 40 mg/30 mg/20 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of this therapeutic drug through legal channels.

What are the storage conditions of Gilotrif® 40 mg/30 mg/20 mg Tablets?

Store these tablets at 20 to 25°C (68 to 77°F); excursions permitted to 15 to 30°C (59 to 86°F). Dispense it in the original container to protect from exposure to high humidity and light.